Testimony

Letter in Support for Teen Pregnancy Prevention Funding

Jul 20th, 2017

TO:                Senator Chris Van Hollen
FROM:          Dr. Leana Wen, Baltimore City Health Commissioner
RE:                Support for Adolescent Health Education

Dear Senator Van Hollen:

On July 6, 2017, the Baltimore City Health Department (BCHD) received notice from the Department of Health and Human Services’ Office of Adolescent Health (OAH) that the grant period for the U Choose evidence-based program would be shortened by two years, which will reduce the overall funding for this program by $3.5M over two years. This change will result in reduced access to evidence-based teen pregnancy curricula for thousands of students in Baltimore, creating a vacuum of critical health education for thousands of vulnerable teens.

Testimony in favor of SB 868 Prescribing and Dispensing Naloxone to Non-certificate Holders

Mar 16th, 2017

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Finance Committee on behalf of Dr. Wen on March 16, 2017.

Testimony in favor for HB 909 Maryland Health Insurance Coverage Protection Act

Mar 11th, 2017

Following is testimony given by Legislative Director Jeff Amoros. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 10, 2017.

Testimony in favor for SB 669 Tobacco Products - Minimum Age and Civil Fines

Mar 9th, 2017

Following is testimony given by Emilie Gilde, Director of Tobacco Use and Cardiovascular Disease Prevention. The statement was presented to the Finance Committee on behalf of Dr. Wen on March 9, 2017.

Testimony in favor of SB 988 Maryland Community Health Worker Act

Mar 9th, 2017

Following is testimony given by Margret Schnitzer, Director of the Community Asthma Program. The statement was presented to the Education, Health, and Environmental Affairs on behalf of Dr. Wen on March 9, 2017.

Testimony in Favor of Co-Prescribing Naloxone Saves Lives Act of 2017

Mar 8th, 2017

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 1, 2017.

Testimony in Favor of HB 1329 Heroin and Opioid Prevention Effort (HOPE) and Treatment Act of 2017

Mar 8th, 2017

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 7, 2017.

Testimony in Favor of SB415 for Prescription Drug Affordability

Feb 24th, 2017

Following testimony was provided by Dr. Leana Wen, Baltimore City Commissioner of Health, to the Finance Committee on February 15, 2017.

Testimony in Favor of HB001/SB230 for Paid Sick Leave

Feb 24th, 2017

Following is testimony given by Dr. Leana Wen, Baltimore City Health Commissioner, presented to the Economic Matters Committee on February 10, 2017.

Testimony in Favor of HB 613 to Permit Licensed Pharmacists to Prescribe and Dispense Contraceptives

Feb 24th, 2017

Following is testimony given by Rebecca Dineen, Deputy Commissioner of Maternal and Child Health. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on February 10, 2017.

Pages